What did Teleflex Incorporated pay for Palette Life Sciences AB?

Teleflex Incorporated acquired Palette Life Sciences AB for $600.0M in 2023, equivalent to 10.70x revenue. Target revenue was approximately $56.0M.

What does Palette Life Sciences AB do?

Palette Life Sciences AB is a medical devices business.

What multiple did Teleflex Incorporated pay for Palette Life Sciences AB?

10.70x revenue, based on disclosed deal value of $600.0M and disclosed financials.

M&A TRANSACTION · 2023

Palette Life Sciences AB acquired by Teleflex Incorporated

$600.0M· 10.70x revenue

Target

Palette Life Sciences AB

Acquirer

Teleflex Incorporated

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$56.0M

EBITDA

—

Deal Value

$600.0M

EV/EBITDA

—

Context

This $600.0M acquisition of Palette Life Sciences AB by Teleflex Incorporated sits in the medical devices sub-vertical. Teleflex Incorporated is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from Press release. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Palette Life Sciences AB acquisition.

Citation: ExitValue.ai. (2023). Palette Life Sciences AB acquired by Teleflex Incorporated. https://exitvalue.ai/deals/palette-life-sciences-ab-acquired-by-teleflex-incorporated-hc-2023-0043